CIDRAP-ASP Report – Bringing Value to the Care Pathway: The Rising Role of Rapid Diagnostics

  22 September 2023

In the second of a three-part series, CIDRAP-ASP explores the role of outcomes research in making the value case for rapid diagnostics that help to identify infectious diseases and prevent antimicrobial resistance (AMR). 

The report also features two case studies on the role of outcomes research in: 1) clarifying the cost-effectiveness of rapid diagnostics for sepsis in different health contexts and 2) evaluating the cost-effectiveness of rapid diagnostics for invasive fungal infections in people living with HIV in Guatemala.

Further reading: CIDRAP
Author(s): Francesca Chiara and Natalie Vestin
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed